source
- Novartis CEO says Trump’s drug pricing plan creates a very difficult situation for makers and patientsNovartis chief executive Vas Narasimhan warned that the United States drug‑pricing policy under President Trump presents a "very difficult situation" for both drugmakers and patients. He said the…
- Novartis CEO warns of impact from Germany's €60 billion healthcare spending cutsNovartis chief executive Vas Narasimhan said the company is very disappointed by Germany's proposal to reduce healthcare spending by more than €60 billion. He expressed concern that the cuts could…